The liquid biopsy is an advanced cancer diagnostic test that uses bio-fluids such as blood, plasma, and urine for detecting cancer cells that are circulating in the blood.
Global Liquid Biopsy Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Liquid Biopsy market, which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end-users, applications, product type, technologies, competitive benchmarking, etc.
Market Opportunities
According to MarkNtel Advisors’ research report titled “Global Liquid Biopsy Market Analysis, 2020”, the Global Liquid Biopsy market is anticipated to grow at a CAGR of around 26% during 2021-26F. The liquid biopsy is used to determine the most ideal cancer therapy for the patient and helps the doctor to track how a patient is responding to treatment and to check whether cancer has returned or not. The robust enhancements in NSG technology, surge in the clinical trials for the development of these tests, coupled with burgeoning cancer cases and a paradigm shift toward noninvasive procedures are some of the key drivers proliferating the growth of the global liquid biopsy market.

Market Segmentation
Automotive Segment Acquired the Considerable Market Share
Based on Circulating Biomarkers, Circulating Tumor Cells (CTCs) segment is expected to grow at a high rate in the Global Liquid Biopsy Market in 2020. The CTC's liquid biopsy tests are used to look for whole tumor cells found in the bloodstream. The rising in CTCs in a patient’s bloodstream leads to cancer progression, while a decrease leads to cancer remission. Thus, this is anticipated to drive the growth of the Liquid Biopsy market globally in the near future as stated in the MarkNtel Advisors’ research report “Global Liquid Biopsy Market Analysis, 2020”.
Impact of COVID-19
Steady growth in the liquid biopsy market has been witnessed in the COVID-19 pandemic and it is used to improve cancer screening and care during COVID-19. Moreover, the rising partnerships among the companies to develop commercialize saliva-based liquid biopsy tests for head and neck cancers, COVID-19 testing and other viral diseases are projected to upsurge the growth of the market in the near future.
Competitive Landscape
According to MarkNtel Advisors, the key players with a considerable market share in the Global Liquid Biopsy market include Bio-Rad Laboratories, Biocept Inc, Abcodia Ltd, Chronix Biomedical, Epic Sciences Inc, Hoffmann-La Roche AG, Cynvenio Biosystems, Inc., GUARDANT HEALTH, INC, Illumina, Inc., NeoGenomics Laboratories, Inc., Menarini Silicon Biosystems, Inc., Qiagen N.V., Thermo Fisher Scientific, Personal Genome Diagnostics, Inc., Qiagen N.V., etc.
Key Questions Answered in the Market Research Report:
- What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of the Global Liquid Biopsy Market?
- What is the region-wise industry size, growth drivers, and challenges key market trends?
- What are the key innovations, technology upgrades, opportunities, regulations in the Global Liquid Biopsy Market?
- Who are the key competitors or market players and how they perform in the Global Liquid Biopsy Market based on the competitive benchmarking matrix?
- What are the key results derived from the market surveys conducted during the course of the Global Liquid Biopsy Market study?
Market Outlook, Segmentation, and Statistics
- Impact of COVID-19 on Global Liquid Biopsy Market
- Global Liquid Biopsy Market Venture Capital Ecosystem
- Financing by Key Investors
- Financing Recipient Wise Details
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Work Process
- Sample Preparation
- Library Preparation
- Sequencing
- Data Analysis
- By Technology
- PCR
- RT-PCR
- dPCR
- Multiplex PCR
- Others
- NGS
- FISH
- Other Technologies
- By Usage
- By Sample Type
- Blood
- Urine
- Saliva
- Cerebrospinal Fluid
- By-Products
- Test /Services
- Kits and Consumables
- Instruments
- By Circulating Biomarkers
- Circulating Tumor cells
- Cell-free DNA
- Circulating Cell-Free RNA
- Exosomes and Extracellular Vesicles
- Others
- By Disease Type
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Melanoma
- Other Cancers
- Non-Oncology Disorders
- By Clinical Application
- Treatment Monitoring
- Prognosis and Recurrence Monitoring
- Treatment Selection
- Diagnosis and Screening
- By Region
- North America Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- The US Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- Canada Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- Mexico Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- South America Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- Brazil Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- Europe Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- The UK Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- Germany Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- France Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- Italy Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- Spain Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- Middle East & Africa Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- UAE Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- Saudi Arabia Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- South Africa Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- Asia-Pacific Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- China Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- Japan Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- South Korea Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- India Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- South East Asia Liquid Biopsy Market Outlook, 2016-2026F (USD Million)
- By Company
- Competition Characteristics
- Market Share & Analysis
- Competitive Matrix
- Global Liquid Biopsy Market List of Biopsies Approved by The Governments
- Global Liquid Biopsy Market Policies, Regulations, Product Standards
- The United States
- European Union
- Global Liquid Biopsy Market Intellectual Property Rights Insights
- Patent Portfolio of Leading Players
- Patent Filings, Registrations and Expiration
- Global Liquid Biopsy Market Hotspots & Opportunities
- Competition Outlook
- Competitor Wise Growth Strategies
- Company Profiles
Frequently Asked Questions:
Q. What is the historical year, base year and forecast year considered in the research report on Global Liquid Biopsy Market?
A. The historical data has been provided since 2016, while the base year is 2020 and the data is forecast up-to 2026.
Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Million.
Q. What would be the growth rate or CAGR of Global Liquid Biopsy Market during 2021-26F?
A. The Global Liquid Biopsy Market is forecast to grow at a CAGR of 26% during 2021-26F.
Q. Who are the key competitors or players operating in Global Liquid Biopsy Market?
A. Bio-Rad Laboratories, Biocept Inc, Abcodia Ltd, Chronix Biomedical, Epic Sciences Inc, Hoffmann-La Roche AG, Cynvenio Biosystems, Inc., GUARDANT HEALTH, INC, Illumina, Inc., NeoGenomics Laboratories, Inc., Menarini Silicon Biosystems, Inc., Qiagen N.V., Thermo Fisher Scientific, Personal Genome Diagnostics, Inc., Qiagen N.V. are few of the leading players in the Global Liquid Biopsy Market.
Q. Which sample type segment would emerge as an opportunity area for players in Global Liquid Biopsy Market?
A. Blood is expected to attain the highest CAGR during the forecast period and maintain its significant market share.
Q. Which region would emerge as an opportunity area for players in Global Liquid Biopsy Market?
A. Asia-Pacific continue to grow at a highest CAGR, presenting immense opportunities for market players of Global Liquid Biopsy Market.